---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-338026"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2025-12-31T23:59:59+00:00"
generated_at: "2026-05-16T11:55:06.490048+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics reports equity above $2.5M after deals; awaits Nasdaq compliance decision

## Summary
- Warrant inducement netted $3.8M; holders exercised 1.51M shares at $2.66, received new warrants at $2.41.
- Issued shares under standby equity line in Q4 2025 for net proceeds of $363,858, boosting equity.
- Settled $7.4M legal fees for $2.0M cash ($500K paid, $1.5M due on license fee receipt); expects $5.4M equity gain.
- Company states stockholders' equity now exceeds $2.5M minimum; awaits Nasdaq formal verification.

## SEC filing metadata
- accession: 0001193125-25-338026
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2025-12-31T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000119312525338026/0001193125-25-338026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000119312525338026/hcwb-20251230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-338026
- JSON: https://secwatch.observer/filing/0001193125-25-338026.json
- Plain text: https://secwatch.observer/filing/0001193125-25-338026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.